JNJON

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

NameJNJON

RankNo.3477

Market Cap$0.00

Fully Diluted Market Cap$0.00

Market Share%

Trading Vol/Market Cap (24H)1,601,287.87%

Circulation Supply54.20547086

Max Supply0

Total Supply54.20547086

Circulation Rate%

Issue Date--

The price at which the asset was first issued--

All-Time High250.607309426007,2026-03-02

Lowest Price203.9667432969526,2026-01-09

Public BlockchainETH

IntroductionJohnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

Sector

Social Media

• Official Website
• Block Explorer

etfindex:mc_etfindex_sourceDisclaimer: Data provided by cmc and should not be considered as investment advice.